ABBIGAIL BRAUCH: Open Payments
NPI 1093231383 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 5 payments from 5 companies in 2025. Trend: 2023 $863 · 2024 $541 · 2025 $608
Food & beverage: $608
| Company | Payments | Amount |
|---|---|---|
| Syndax Pharmaceuticals, Inc. | 1 | $149 |
| Galvanize Therapeutics, Inc | 1 | $130 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Incyte Corporation | 1 | $125 |
| Merck Sharp & Dohme LLC | 1 | $79 |
Products named: REVUFORJ, ALIYA SYSTEM, Monjuvi, KEYTRUDA.
Industry payments across WI — which companies pay providers there.
